Andrew Sheets: November’s Early Holiday Gift to Investors

Andrew Sheets: November’s Early Holiday Gift to Investors

The market rally of the last few weeks is based on strong economic data, suggesting that the U.S. and Europe remain on track for a “soft landing.”


----- Transcript -----

Welcome to Thoughts on the Market. I'm Andrew Sheets, Global Head of Corporate Credit Research for Morgan Stanley. Along with my colleagues bringing you a variety of perspectives, I'll be talking about trends across the global investment landscape and how we put those ideas together. It's Friday, December 1st at 2 p.m. in London.

November 2023 is now in the history books. It was outstanding. US bonds rose 4.5%, the best month since 1985. Global stocks rose 9%, the best month in three years. Spreads on an investment grade and high yield bonds tightened significantly. With the exception of commodities and Chinese stocks, which both struggled, November was an early holiday gift to investors of many stripes.


While the size of the rally in November was unusual, the direction didn't just spring from thin air. Generally speaking, economic data in November strongly endorsed the idea of a soft landing. Soft landing, where inflation falls without a sharp drop in economic activity are historically rare. But they are Morgan Stanley's economic forecast for the year ahead. And in November, investors unwrapped data suggesting the story remains on track.


In the US, core consumer price inflation declined more than expected. Core PCE inflation, a slightly different measure that the Federal Reserve prefers, has fallen down to an annualized pace of just 2.5% over the last six months. Gas prices are down 16% since the summer, rental inflation has stalled and the U.S. auto production is normalizing, improving the trend in three big drivers of the higher inflation we've seen over the last two years.


Go back 12 months and most forecasts, including our own, assume that lower inflation would be the result of higher interest rates driving a slowdown in growth. But the economy has been good. Over the last 12 months, the U.S. economy has grown 3%, .5% better than the average since 1990.


The story in Europe is a little different from the one in America, but it still rhymes. In Europe, recent inflation data has also come in lower than expected. While economic data has been somewhat weaker. Still, we see signs that the worst of Europe's economic growth will be confined to 2023 and continue to forecast the weakest growth right now, with somewhat better European growth in 2024.


Why does this matter? While the returns of November were unusual and unlikely to repeat, it's a good reminder not to overcomplicate things. Good data, by which we mean lower inflation and reasonable growth, is a good outcome that markets will reward, and remains the Morgan Stanley economic base case. Deviating on either variable is a risk, especially for an asset class like credit. Following the data and keeping an open mind, remains important.

Thanks for listening. Subscribe to Thoughts on the Market on Apple Podcasts or wherever you listen and leave us a review. We'd love to hear from you.

Avsnitt(1513)

Andrew Sheets: Supply Also Matters

Andrew Sheets: Supply Also Matters

On today's episode, Discussions about financial markets often center on issues of demand. Andrew Sheets takes a look at the supply trends that may impact debt and equity markets globally in 2020.

7 Feb 20203min

Michael Zezas: The Limited Lives of Multiple Narratives

Michael Zezas: The Limited Lives of Multiple Narratives

On today's episode, Recent events have added little clarity to the policy choices U.S. voters will face in the November presidential elections, but that won't last forever.

5 Feb 20202min

Mike Wilson: The Tug of War for U.S. Equites

Mike Wilson: The Tug of War for U.S. Equites

On today's episode, U.S. equities face concerns over global growth—caused by the coronavirus and other catalysts—but plentiful liquidity from the Fed. Thoughts on positioning from Chief Investment Officer Mike Wilson.

4 Feb 20203min

Jonathan Garner: What Can SARS Tell Us About the Coronavirus?

Jonathan Garner: What Can SARS Tell Us About the Coronavirus?

On today's episode, To understand the impact of the Coronavirus on humanity, economics and markets, Chief Asia and Emerging Markets Equity Strategist Jonathan Garner draws parallels with the 2002 SARS outbreak.

31 Jan 20203min

Andrew Sheets: Coronavirus Affects the Narrative

Andrew Sheets: Coronavirus Affects the Narrative

On today's episode, Nations try to address the public health impact of the coronavirus alongside uncertainty about the global outlook for 2020. Perspective from Andrew Sheets, Chief Cross-Asset Strategist.

30 Jan 20202min

Andrew Sheets: Are More Countries Saying Deficits Don’t Matter?

Andrew Sheets: Are More Countries Saying Deficits Don’t Matter?

On today's episode, Only a decade ago, market analysts and political observers were saying sovereign deficits were bad. Cross-Asset Strategist Andrew Sheets explains why that view may be changing.

29 Jan 20203min

Michael Zezas: Taxation Complicates U.S.-EU Trade

Michael Zezas: Taxation Complicates U.S.-EU Trade

On today's episode, Although the U.S and China have found a way forward on trade negotiations, a clear path for U.S.-EU trade is getting slightly more complicated.

27 Jan 20201min

Andrew Sheets: As 2020 Begins, Investors Get Optimistic

Andrew Sheets: As 2020 Begins, Investors Get Optimistic

On today's episode, Skepticism was the prevailing investor attitude for most of 2019, but what a difference a quarter can make. So what changed? Chief Cross-Asset Strategist Andrew Sheets talks changing sentiment as 2020 kicks off.

24 Jan 20203min

Populärt inom Business & ekonomi

badfluence
framgangspodden
varvet
rss-jossan-nina
rss-svart-marknad
uppgang-och-fall
affarsvarlden
bathina-en-podcast
rss-borsens-finest
24fragor
avanzapodden
borsmorgon
rss-inga-dumma-fragor-om-pengar
rss-kort-lang-analyspodden-fran-di
kapitalet-en-podd-om-ekonomi
rss-dagen-med-di
lastbilspodden
rss-en-rik-historia
tabberaset
market-makers